Xenon Pharmaceuticals (XENE) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.77
-0.72
-0.67
-0.62

Details

Expected EPS
-0.664154
Actual EPS
-0.62
Surprise EPS
0.04
Surprise Percent
+6.65%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -0.62 per share for Q2 2024.

0 Comments

Share your thoughts